Premas Biotech Reports Positive Preliminary Phase-1 Data for its Oral Covid-19 Vaccine, developed for Oravax Medical
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical Inc Primary
Read More